ý

Our News on Newswise

Newswise: 67632afed55e4_chandra-lab-hero-image.jpeg

Roswell Park Team Discovers New Treatment Target for Neuroendocrine Prostate Cancer

A team of researchers at Roswell Park , led by Dhyan Chandra, PhD, has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat form of prostate cancer. Their findings, newly published in the journal Oncogene,...
18-Dec-2024 8:05 PM EST Add to Favorites

Newswise: 6760909701b38_GMPPressConferenceDecember2024-34-3.jpg

Governor Hochul Celebrates the Opening Of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center in Buffalo

Governor Kathy Hochul today celebrated the opening of the Roswell Park GMP Engineering and Cell Manufacturing Facility, New York's first cell and gene therapy hub, located at Roswell Park Comprehensive Cancer Center in Buffalo. The $98 million...
16-Dec-2024 9:10 PM EST Add to Favorites

Newswise: 675b3486269aa_ZsirosEmese090222047Edit.jpg

Roswell Park Team Identifies Factors That Boost Effectiveness of Immunotherapy in Recurrent Ovarian Cancer

A study led by Roswell Park provides new insight into the complex interactions of the “tumor-immune-gut axis,” and its role in influencing immunotherapy responses in patients with recurrent ovarian cancer. Newly published in Nature...
12-Dec-2024 8:35 PM EST Add to Favorites

Newswise: 675735e810a1d_Hernandez-IlizaliturriFranciscoSeptember202022-3.jpg

Could Venetoclax Improve Outcomes of CAR T for Patients with Resistant B-Cell Lymphomas? New Insights at ASH

About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, will see their disease advance or recur following treatment. Seeking a new treatment strategy that might boost the effectiveness of existing DLBCL...
9-Dec-2024 7:30 PM EST Add to Favorites

Newswise: 675394e08da23_Hillengass-Joseph.jpg

Resistance Training Can Reduce Fatigue, Pain in Multiple Myeloma Patients, Roswell Park Team Shows

Researchers from Roswell Park Comprehensive Cancer Center will present compelling findings showcasing significant benefits of resistance training for patients with multiple myeloma, in a talk at the 66th American Society of Hematology (ASH) Annual...
8-Dec-2024 4:30 PM EST Add to Favorites

Newswise: 67525b16a621a_Kelly-Cortese.122414copy.jpg

Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin Lymphoma

The results of two important lymphoma studies led by experts at Roswell Park Comprehensive Cancer Center will be presented during oral abstract sessions this morning at the 66th annual meeting of the American Society of Hematology (ASH) in San...
8-Dec-2024 12:30 PM EST Add to Favorites

Newswise: 67533c9ccabb5_NiswanderLisa9.24.24-1.jpg

Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias

A preclinical study led by a faculty member at Roswell Park Comprehensive Cancer Center shows that gilteritinib (brand name Xospata), a targeted cancer treatment, can strengthen chimeric antigen receptor (CAR) T-cell immunotherapy in two high-risk...
7-Dec-2024 7:00 PM EST Add to Favorites

Newswise: 67525a3e1213a_CorteseMatthewJuly1420222.jpg

Roswell Park Study Reveals How Venetoclax Boosts Immune Response to CAR T for Chronic Lymphocytic Leukemia

Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug venetoclax (brand name Venclexta) works synergistically with CAR T-cell immunotherapy to combat chronic lymphocytic leukemia (CLL), the most common type of...
7-Dec-2024 12:30 PM EST Add to Favorites


See All News

Our Experts on Newswise

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

See All Experts

About

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or [email protected].

Experts

Twitter

close
0.35197